European Companies Search Engine
UK funding (£31,750): Doped Titania for Cancer Therapy Ukri1 Sept 2012 UK Research and Innovation, United Kingdom
Overview
Text
Doped Titania for Cancer Therapy
| Abstract | This project aims to scale-up and integrate into the current supply chain a technology developed at Oxford University. Preliminary research has shown that rare earth doped titania nanoparticles are highly effective at augmenting radiotherapy in the treatment of cancerous tumours. The main aims of this project are to move the technology of the particle synthesis from the lab-bench to commercial scale – it is proposed to use flame spray pyrolysis (developed by Johnson Matthey) to achieve this, and through this technique, further enhance the efficacy of the technology. It is felt that the synergy of the two collaborators on this project are best placed to allow for the realisation of this ambitious project. |
| Category | Collaborative R&D |
| Reference | 101166 |
| Status | Closed |
| Funded period start | 01/09/2012 |
| Funded period end | 31/10/2014 |
| Funded value | £31,750.00 |
| Source | https://gtr.ukri.org/projects?ref=101166 |
Participating Organisations
| JOHNSON MATTHEY PLC |
£31,750.00 |
| UNIVERSITY OF OXFORD |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Johnson Matthey plc, London.
